Compare PFAI & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PFAI | NEPH |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | Canada | United States |
| Employees | 13 | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4M | 40.1M |
| IPO Year | N/A | 2004 |
| Metric | PFAI | NEPH |
|---|---|---|
| Price | $3.75 | $3.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 1.7K | ★ 19.2K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1000.00 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $18,789,000.00 |
| Revenue This Year | N/A | $11.24 |
| Revenue Next Year | N/A | $11.58 |
| P/E Ratio | ★ N/A | $333.00 |
| Revenue Growth | N/A | ★ 32.67 |
| 52 Week Low | $1.30 | $2.66 |
| 52 Week High | $4.93 | $6.42 |
| Indicator | PFAI | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 44.53 |
| Support Level | $3.53 | $2.72 |
| Resistance Level | $4.09 | $3.79 |
| Average True Range (ATR) | 0.11 | 0.17 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 38.46 | 7.81 |
Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.